Lincoln Pharmaceuticals Ltd
LINP.NS
$8.63
Closing
▼-0.71%
1D
▼-5.33%
YTD
LINP
BBG001S8X912
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$172.80M
Analysts' Rating
-
Price Target (Mean)
0.00
Total Analysts
0
P/E
15.46
Operating Margin
15.38%
Beta
0.79
Revenue Growth
3.35%
52 week high
$11.33
52 week low
$6.19
Div. Yield
0.24%
EPS Growth
0.00
Company Profile
Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading of pharmaceutical products like medicines, injections and other related products. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, anti-diabetic, and anti-malaria. The Company serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company’s products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms), and Tinnex Capsule used to treat tinnitus.
